Fifth Third Wealth Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History
Fifth Third Wealth Advisors LLC
- $1.32 Trillion
- Q2 2024
A detailed history of Fifth Third Wealth Advisors LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Fifth Third Wealth Advisors LLC holds 397 shares of REGN stock, worth $402,089. This represents 0.03% of its overall portfolio holdings.
Number of Shares
397
Previous 225
76.44%
Holding current value
$402,089
Previous $217 Million
92.68%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding REGN
# of Institutions
1,464Shares Held
84.4MCall Options Held
907KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$9.11 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$8.55 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY8.28MShares$8.38 Billion0.77% of portfolio
-
State Street Corp Boston, MA4.84MShares$4.9 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$4.7 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $109B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...